Venous Thromboembolism with Contemporary Lenalidomide-Based Regimens and Adequate Thromboprophylaxis in Newly Diagnosed Multiple Myeloma: A Systemic Review and Meta-Analysis

被引：0
|
作者：
Chakraborty, Rajshekhar [1 ]
Malik, Saad Ullah [2 ]
Marneni, Naimisha [3 ]
Garcia, Alex V. Mejia [3 ]
Anwer, Faiz [1 ,4 ]
Khorana, Alok A. [5 ]
Majhail, Navneet S. [6 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Univ Arizona, Tucson, AZ USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Univ Arizona, Tucson, AZ USA
[5] Cleveland Clin Fdn, Taussig Canc Ctr, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[6] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4835
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis
    Thierry Facon
    Jesús San-Miguel
    Meletios A. Dimopoulos
    Maria-Victoria Mateos
    Michele Cavo
    Sophie van Beekhuizen
    Zijiao Yuan
    João Mendes
    Annette Lam
    Jianming He
    Eric Ammann
    Shaji Kumar
    Advances in Therapy, 2022, 39 : 1976 - 1992
  • [32] Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis
    Jiasheng Wang
    Yeseong Kim
    International Journal of Hematology, 2020, 112 : 650 - 657
  • [33] Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
    McCarthy, Philip L.
    Holstein, Sarah A.
    Petrucci, Maria Teresa
    Richardson, Paul G.
    Hulin, Cyrille
    Tosi, Patrizia
    Bringhen, Sara
    Musto, Pellegrino
    Anderson, Kenneth C.
    Caillot, Denis
    Gay, Francesca
    Moreau, Philippe
    Marit, Gerald
    Jung, Sin-Ho
    Yu, Zhinuan
    Winograd, Benjamin
    Knight, Robert D.
    Palumbo, Antonio
    Attal, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3279 - +
  • [34] Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients: Meta-analysis of Efficacy in Pivotal Randomized Controlled Trials
    Manier, Salomon
    Robinson, Suzanne
    Owen, Melody
    Dhanasiri, Sujith
    Frederickson, Andrew
    Jackson, Graham
    Facon, Thierry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E9 - E10
  • [35] Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
    Botta, Cirino
    Martino, Enrica Antonia
    Conticello, Concetta
    Mendicino, Francesco
    Vigna, Ernesto
    Romano, Alessandra
    Palumbo, Giuseppe Antonio
    Cerchione, Claudio
    Martinelli, Giovanni
    Morabito, Fortunato
    Di Raimondo, Francesco
    Gentile, Massimo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis
    Costa, Bruno Almeida
    Costa, Thomaz Alexandre
    Pak, Kevin
    Patel, Aesha
    Felix, Nicole
    Mouhieddine, Tarek H.
    Richter, Joshua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1411 - 1414
  • [37] Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
    Filho, Joao Tadeu Damian Souto
    Cantadori, Lucas Oliveira
    Crusoe, Edvan de Queiroz
    Hungria, Vania
    Maiolino, Angelo
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [38] Correction to: Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis
    Thierry Facon
    Jesús San-Miguel
    Meletios A. Dimopoulos
    Maria-Victoria Mateos
    Michele Cavo
    Sophie van Beekhuizen
    Zijiao Yuan
    João Mendes
    Annette Lam
    Jianming He
    Eric Ammann
    Shaji Kumar
    Advances in Therapy, 2022, 39 : 3868 - 3869
  • [39] Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis
    Qin, Jiading
    Ke, Bo
    Liu, Tingting
    Kong, Chunfang
    Li, Anna
    Fu, Huan
    Jin, Chenghao
    CANCER MEDICINE, 2023, 12 (03): : 2199 - 2218
  • [40] Comparative Efficacy of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Vs. Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRD) in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
    Wang, Yuqi
    Huan, Chen
    Hanzhen, Zhang
    Zhang, Shanshan
    Yuan, Youhai
    Feng, Ru
    Wei, Yongqiang
    Wei, Xiaolei
    BLOOD, 2024, 144 : 7031 - 7031
12345